Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FitRx vs Midi Health

FitRx
Graded #196

Higher grade

vs+9.800000000000004
Midi Health
Graded #413

Lower grade

The verdict

FitRx takes it — 66.2/100 to 56.4/100.

FitRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFitRx +18
63
45
Dose & formulationFitRx +25
65
40
Clinical oversightMidi Health +2
76
78
Labs & monitoringFitRx +1
53
52
FulfillmentFitRx +10
88
78
Contract termsMidi Health +8
47
55
FitRx · left barMidi Health · right bar

The numbers

MetricFitRxMidi Health
WeighScore66.2/10056.4/100
GradeCC
Scorecard rank#196#413
Semaglutide$151/mo (quarterly plan, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
FitRx

Graded #196 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • LegitScript certified
  • All 50 states + DC coverage
  • Compounded semaglutide from $151/mo quarterly for uninsured patients

Where it loses points

  • Insurance coordination may not work for all plans
  • Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
  • Compounded option is semaglutide only — no compounded tirzepatide
Midi Health

Graded #413 · C

Strengths

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Where it loses points

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard